Eastman Chemical — Jul 30, 2026 release
Fiscal 2026 second-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0000915389-26-000138
Showing in the filing
Adjusted EPS
“approach second-quarter 2026 EPS of $1.97”
Period
Q3 FY2026
Measure
Company-defined measure
Source
Prose
All guidance in this release · 12
Working capital for FY2026
“expect to release working capital in the second half of 2026”
Cost reduction, net of inflation for FY2026
“between $125 million and $150 million”
Reduce costs, net of inflation
“between $125 million and $150 million”
Capital expenditures for FY2026
“approximately $400 million”
Earnings growth vs. prior year for FY2026
“significantly improve earnings in 2026 versus 2025”
Operating cash flow for FY2026
“approach $900 million”
Advanced Materials EBIT (sequential) for Q3 FY2026
“expect EBIT to be higher”
Fibers earnings (sequential) for Q3 FY2026
“expect higher earnings in Fibers”
Additives & Functional Products earnings (se… for Q3 FY2026
“expected to decline modestly”
Chemical Intermediates earnings (sequential) for Q3 FY2026
“expected to modestly decline”
Adjusted diluted EPS for Q3 FY2026
“approach second-quarter 2026 EPS of $1.97”
Adjusted EPS for Q3 FY2026
“approach second-quarter 2026 EPS of $1.97”
Exhibit 99.1 · the passage around this item
… earlier in the release
Additives & Functional Products earnings are expected to decline modestly due to seasonally lower volume, particularly in the agriculture market. Chemical Intermediates earnings are expected to modestly decline as the impact of supply chain disruptions lessens. When putting these factors together, we project third-quarter adjusted EPS to approach second-quarter 2026 EPS of $1.97." The third-quarter 2026 projected adjusted diluted EPS excludes any non-core, unusual, or nonrecurring items. Our financial results forecasts do not include non-core items (such as mark-to-market pension and other post-retirement benefit gain or loss, and asset impairments and restructuring charges) or any unusual or non-recurring items because we are unable to predict with reasonable certainty the financial impact of such items. These items are uncertain and depend on various factors, and we are unable to reconcile projected adjusted diluted EPS excluding non-core and any unusual or non-recurring items to reported GAAP diluted EPS without unreasonable efforts. Forward-Looking Statements The information in this release and other statements by the company may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act with respect to, among other items: projections and estimates of earnings, revenues, volumes, pricing, margins, sales, cost reductions, expenses, taxes, liquidity, capital expenditures, cash flow, dividends, share repurchases or other financial items, supply and demand, capacity and utilization, growth opportunities, statemen
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.